NTRK1 and glioblastoma: Some well-known biological pathway alterations in GBM are phosphatidylinositol-3-OH kinase (PI3K) pathway activation and growth factor signalling defects depending on receptor tyrosine kinase (RTK) activation [7,8] that are confirmed based on KEGG pathway functional enrichment analysis (Figure 3(A.2)).